Principal Financial Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $14.7K | Sell |
|
|||||
|
2025
Q2 | $166K | Sell |
|
|||||
|
2025
Q1 | $254K | Buy |
|
|||||
|
2024
Q4 | $174K | Buy |
|
|||||
|
2024
Q3 | $204K | Buy |
|
|||||
|
2024
Q2 | $64.6K | Sell |
|
|||||
|
2024
Q1 | $100K | Sell |
|
|||||
|
2023
Q4 | $62.7K | Buy |
|
|||||
|
2023
Q3 | $35.9K | Buy |
|
|||||
|
2023
Q2 | $39.1K | Buy |
|
|||||
|
2023
Q1 | $46.6K | Sell |
|
|||||
|
2022
Q4 | $82.7K | Buy |
|
|||||
|
2022
Q3 | $113K | Sell |
|
|||||
|
2022
Q2 | $76K | Sell |
|
|||||
|
2022
Q1 | $163K | Buy |
|
|||||
|
2021
Q4 | $254K | Sell |
|
|||||
|
2021
Q3 | $401K | Buy |
|
|||||
|
2021
Q2 | $556K | Sell |
|
|||||
|
2021
Q1 | $630K | Sell |
|
|||||
|
2020
Q4 | $867K | Buy |
|
|||||
|
2020
Q3 | $482K | Sell |
|
|||||
|
2020
Q2 | $496K | Buy |
|
|||||
|
2020
Q1 | $269K | Buy |
|
|||||
|
2019
Q4 | $501K | Buy |
|
|||||
|
2019
Q3 | $208K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $228K | Buy |
|
|||||
|
2018
Q4 | $238K | Sell |
|
|||||
|
2018
Q3 | $386K | Sell |
|
|||||
|
2018
Q2 | $579K | Buy |
|